NDC 17856-0874-03 - LACTULOSE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0874
- Requested NDC
- 17856-0874-03
- Package NDCs from labels
- 17856-0874-3, 17856-0874-03
- Manufacturer
- Atlantic Biologicals Corp.
- Effective date
- 2025-09-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lactulose Solution USP 10 g/15 mL | Atlantic Biologicals Corp. | 2025-09-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0874-3 | LACTULOSE | 30 mL in 1 CUP, UNIT-DOSE | SOLUTION | 30 | 1 | |
| 17856-0874-3 | LACTULOSE | 50 in 1 CASE | SOLUTION | 50 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0874-3 | ML - Milliliter | 17856-0874 | 6835883f-8bcc-43f0-8237-dbfc9b6a7f16 | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Generlac | LACTULOSE | Chartwell RX, LLC | 35207edd-a5fe-4369-a079-7a8b0d2f2e91 | 2024-07-16 | Warnings, Adverse reactions | 391937 9U7D5QH5AE |
| LACTULOSE | LACTULOSE | Proficient Rx LP | 6bbabdc6-f6a8-4f67-a448-e452d1928deb | 2024-06-01 | Warnings, Adverse reactions | ANDA074623 391937 9U7D5QH5AE |
| Lactulose Solution | LACTULOSE SOLUTION USP, 10 G/15 ML | Bajaj Medical, LLC | d460b1a2-9091-2ac9-e053-2995a90aa1d2 | 2022-12-26 | Warnings, Adverse reactions | 391937 9U7D5QH5AE |
| Lactulose | LACTULOSE | Fresenius Kabi Austria GmbH | a89835c9-8ce5-4627-8d7d-70ff175b2e07 | 2022-11-09 | Adverse reactions | 391937 9U7D5QH5AE |
| Constulose | LACTULOSE | Actavis Pharma, Inc. | 461ec39f-eeb4-4460-9b5c-62367d47162b | 2022-06-01 | Warnings, Adverse reactions | 391937 9U7D5QH5AE |
| Enulose | LACTULOSE | Actavis Pharma, Inc. | 00c42c5c-d19e-4130-aa08-a8bbd47d3e5b | 2022-06-01 | Warnings, Adverse reactions | 391937 9U7D5QH5AE |
| LACTULOSE | LACTULOSE | Lannett Company, Inc. | 6619b25c-26b7-4c43-8c4f-9d33a23c61ca | 2020-01-30 | Warnings, Adverse reactions | 391937 9U7D5QH5AE |
| KRISTALOSE | LACTULOSE | Cumberland Pharmaceuticals Inc. | 535dd1ea-b567-49f7-9a84-8ea91e78c466 | 2018-09-17 | Warnings, Adverse reactions | 9U7D5QH5AE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.